Abstract

Purine metabolism and transport have been extensively studied in the mammalian erythrocyte; much less, however, is known about corresponding aspects of the metabolism of pyrimidines and their derivatives, or even whether pyrimidine nucleotides have any physiological role in the erythrocyte. Until quite recently it was considered, from studies on stored blood, that negligible metabolism of pyrimidine nucleotides took place in the erythrocyte1. However, if fresh red cells are used it can be shown that both orotate and uridine can be actively taken up and converted to uridine nucleotides; the rate of nucleotide formation from uridine circulating in the plasma has been estimated to be about 0.8 nmol e/min 1010 RBC 2. The rate of uridine nucleotide degradation back to uridine by the pyrimidine-specific 5’ nucleotidase of erythrocytes is of a comparable order, if the properties of this enzyme in cell-free preparations 3,4 apply in the intact cell. Our previous studies on red cell uridine nucleotide degradation after pulse labelling normal and pyrimidine 5’ nucleotidase deficient red cells with (3H) uridine, confirm that rapid conversion to uridine occurs2.KeywordsPurine MetabolismEhrlich Ascites CarcinomaPyrimidine NucleotideMammalian ErythrocyteUridine NucleotideThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.